Gofen & Glossberg’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-150,328
Closed -$14.9M 492
2019
Q3
$14.9M Sell
150,328
-24,576
-14% -$2.34M 0.5% 57
2019
Q2
$16.2M Sell
174,904
-37,812
-18% -$3.59M 0.55% 52
2019
Q1
$20.1M Sell
212,716
-180,764
-46% -$15.8M 0.71% 45
2018
Q4
$25.2M Sell
393,480
-12,644
-3% -$933K 1% 30
2018
Q3
$36.3M Sell
406,124
-2,460
-0.6% -$217K 1.25% 19
2018
Q2
$32.5M Sell
408,584
-419
-0.1% -$34.8K 1.2% 19
2018
Q1
$36.5M Sell
409,003
-10,522
-3% -$1.01M 1.37% 17
2017
Q4
$43.8M Sell
419,525
-5,612
-1% -$633K 1.56% 14
2017
Q3
$62M Sell
425,137
-2,806
-0.7% -$382K 2.3% 7
2017
Q2
$55.6M Buy
427,943
+609
+0.1% +$74.6K 2.11% 7
2017
Q1
$53.2M Sell
427,334
-9,317
-2% -$1.11M 2.08% 8
2016
Q4
$50.5M Sell
436,651
-4,136
-0.9% -$461K 2.06% 8
2016
Q3
$46.1M Sell
440,787
-4,901
-1% -$530K 1.91% 9
2016
Q2
$44M Buy
445,688
+2,963
+0.7% +$306K 1.84% 9
2016
Q1
$44.3M Buy
442,725
+6,420
+1% +$661K 1.89% 9
2015
Q4
$52.3M Buy
436,305
+1,848
+0.4% +$214K 2.27% 7
2015
Q3
$47M Sell
434,457
-6,103
-1% -$757K 2.14% 5
2015
Q2
$51M Buy
440,560
+5,137
+1% +$587K 2.15% 6
2015
Q1
$50.2M Sell
435,423
-9,649
-2% -$1.15M 2.16% 7
2014
Q4
$49.8M Sell
445,072
-11,392
-2% -$1.2M 2.14% 6
2014
Q3
$43.3M Sell
456,464
-6,626
-1% -$598K 1.91% 10
2014
Q2
$39.8M Sell
463,090
-3,294
-0.7% -$250K 1.76% 14
2014
Q1
$37.5M Sell
466,384
-6,080
-1% -$481K 1.75% 13
2013
Q4
$39.9M Sell
472,464
-24,804
-5% -$1.96M 1.87% 10
2013
Q3
$38.3M Sell
497,268
-24,158
-5% -$1.69M 1.97% 8
2013
Q2
$30.5M Buy
+521,426
New +$31.4M 1.65% 14

Other funds holding CELG

Gofen & Glossberg's CELG Position: Q4 2019 in Review

Gofen & Glossberg sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 150,328 shares — an estimated $14.9M sold.

Gofen & Glossberg first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $62M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gofen & Glossberg reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gofen & Glossberg sold 150,328 Celgene Corp shares in Q4 2019, an estimated $14.9M.
  • Gofen & Glossberg first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Gofen & Glossberg's Celgene Corp position peaked at $62M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gofen & Glossberg's 13F filing for Q4 2019, filed 28 Jan 2020.